KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Common Equity (2016 - 2025)

Alto Ingredients' Common Equity history spans 15 years, with the latest figure at $245.2 million for Q4 2025.

  • For Q4 2025, Common Equity rose 8.97% year-over-year to $245.2 million; the TTM value through Dec 2025 reached $245.2 million, up 8.97%, while the annual FY2025 figure was $245.2 million, 8.97% up from the prior year.
  • Common Equity reached $245.2 million in Q4 2025 per ALTO's latest filing, up from $222.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $363.6 million in Q2 2022 to a low of $207.8 million in Q2 2025.
  • Average Common Equity over 5 years is $284.7 million, with a median of $295.8 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 50.3% in 2021, then fell 21.81% in 2025.
  • A 5-year view of Common Equity shows it stood at $345.2 million in 2021, then decreased by 10.75% to $308.1 million in 2022, then dropped by 9.26% to $279.6 million in 2023, then dropped by 19.49% to $225.1 million in 2024, then increased by 8.97% to $245.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALTO's Common Equity are $245.2 million (Q4 2025), $222.4 million (Q3 2025), and $207.8 million (Q2 2025).